Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials-Reference-Cited by-同舟云学术

Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials

Published:2021-08-23 Issue:8 Volume:43 Page:730-741
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Takahashi Toshinari¹^ORCID,Beppu Takanobu²,Hidaka Yuji³,Hosoya Tatsuo⁴

Affiliation:

1. Medical Affairs Department, Mochida Pharmaceutical Co., Ltd, Tokyo, Japan

2. Medical Affairs Department, Fuji Yakuhin Co., Ltd, Tokyo, Japan

3. Akasaka Central Clinic, Tokyo, Japan

4. Emeritus professor, Jikei University School of Medicine, Tokyo, Japan

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10641963.2021.1950752

Reference25 articles.

1. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension

2. Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism

3. Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study

4. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation

5. Current status of uric acid level in treated hypertensive patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Dotinurad on Serum Uric Acid Concentration in Chronic Kidney Disease Patients Treated with Febuxostat;Journal of Nippon Medical School;2024-08-25

2. SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids;Frontiers in Cell and Developmental Biology;2024-01-10

3. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review;Drugs;2023-10-11

4. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA);European Journal of Medical Research;2023-07-17

5. Uric acid transport, transporters, and their pharmacological targeting;Acta Physiologica;2023-05-04